Bio-IT WorldUnclaimed
Host of Trends from the Trenches.
1 Feed-stated
Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record
- Host
Claim this profile Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.
This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.
PodCred record
PodCred is the verified record of where Bio-IT has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.
Worked with Bio-IT on a show? This is where you give them credit.
Shows they work on now
1 show
Is an appearance missing?
People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.
No account needed. Anyone can give a credit.
Experience, education, skills, and recommendations start empty. They fill in when Bio-IT claims this profile.
Recommendations
No recommendations for Bio-IT yet.
Recommendations open once Bio-IT claims the profile.
Posts
No posts yet. Posts Bio-IT shares on PodSubs, and what Bio-IT publishes on Substack, YouTube and elsewhere, will show here.
Recent episodes
From the shows they work on now
Episode: 47 - Curved Air and The Long Road To A Sickle Cell Cure
A cure can be real and still feel out of reach. Trends from the Trenches host Allison Proffitt is joined by Kevin Davies, executive editor of The CRISPR Journal and author of Curved Air: A Biography of Sickle Cell...
Episode: 46 - Eric Schadt on Building AI-Native Drug Development And Patient-Facing Care
Trends from the Trenches host Eleanor Howe sits down with computational biologist Eric Schadt - now an AI Scholar in Residence at Pfizer - who has spent 25 years pushing a simple idea with huge consequences: disease is...
Episode: 45 - Ben Busby on Genomics at GPU Speed
Genomics is moving fast, but how do we get biology the hardware and software it deserves? Ben Busby, NVIDIA’s global alliances manager for omics, joins host Eleanor Howe to dig into the practical crossroads of GPU...
Episode: 44 - Knowledge Graphs Turning Life Science Data into Answers
AI is moving fast in life sciences, but a confident answer is not the same thing as a correct, reproducible, auditable answer. Knowledge graphs, ontologies, and FAIR data practices are the keys to bridging this gap....
Episode: 43 - The Hard Truth about Digital R&D: Patterns, Pitfalls, and the Next Wave of Innovation
At last month’s Bio-IT World Conference & Expo, Eleanor Howe, founder and CEO of Diamond Age Data Science, presented the Trends with the Trenches session based on gathered input from colleagues, clients, and advisors...
Episode: 42 - Adam Marko on AI-Ready Life Sciences Data
Your AI plan can’t outrun your data. Adam Marko, life science field CTO at Hammerspace, joins the podcast to unpack the problem almost every biotech, pharma, and biomedical research group runs into: unstructured data...
Episode: 41 - Sonia Timberlake on Agentic AI for Biotech Coders
AI is now good enough to change how computational biology teams actually work, but most companies are still adopting it like it’s 2023. Sonia Timberlake, R&D strategy consultant for Timberlake & Maclsaac Biopharma...
Episode: 40 - Allissa Dillman and LaFrancis Gibson on the Power of Hackathons
Joining Trends from the Trenches is Allissa Dillman, founder and CEO of BioData Sage, and LaFrancis Gibson, manager for health promotion at ORAU, who discuss this year’s Bio-IT World Conference & Expo Hackathon...
Episode: 39 - Jarett DeAngelis and Shane Corder on Simplifying HPC Resources
Computing resources are no longer just pieces of tech - they're scientific instruments. Moffitt Cancer Center’s Jarett DeAngelis, director of scientific information technology, and Shane Corder, senior HPC engineer,...
Episode: 38 - Third Rock’s John Keilty on What Lies Ahead for Bioinvestment
As the new year settles in, the industry is anticipating new innovative biotech and learning from past failures. John Keilty, venture partner at Third Rock Ventures, discusses the current trends he sees in biopharma...
